InflaRx N.V.

IFRX·NasdaqGS·Healthcare
Compare
1.4800−0.1400 (−8.64%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.6200
Open1.6400
Day range1.33001.7190
52-week range0.79802.9490
Off day high−13.90%
Off 52-week high−49.81%
Volume1.90M
Avg. volume (3M)831.33K
Market cap218.10M
EPS (TTM)-0.3700
Forward P/E-4.02
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.61
Shares outstanding147.37M
Short interest9.42% of float
Earnings dateNov 3, 2026
Analyst target8.2880
Profit margin0.00%

Against its peers

Compare in full ›
IFRX RLYB ANNX ARTV CANTA.ST ZURA
Market cap 218.10M 85.60M 820.88M 206.32M 475.36M 387.23M
P/E (TTM) — 3.4 — — 2.5 —
Forward P/E -4.0 -2.9 -4.0 -2.1 -1.8 -5.9
Price/book 2.3 0.9 4.1 0.6 1.6 2.2
Dividend yield — — — — — —
1-year change +30.65% +217.20% +43.38% +22.09% −48.13% +9.92%
Today −8.64% +0.25% +3.34% +0.48% −2.09% +0.75%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IFRX news ›
markets.businessinsider.com·Positive

InflaRx to Host Virtual Capital Markets Day

Featuring leading experts in the fields of AAV and complement inhibition, the virtual event will provide an overview of the evolving treatment landscape and unmet need in AAV, and how izicopan’s differentiated chemistry, metabolic…

markets.businessinsider.com·Positive

InflaRx initiated with a Buy at Needham

Needham initiated coverage of InflaRx (IFRX) with a Buy rating and $8 price target InflaRx’s izicopan offers potentially significant upside in ... InflaRx initiated with a Buy at Needham Needham initiated coverage of InflaRx (IFRX) with a…

From the 4Search news index, newest first.

In the news

9mentions in 30 days
9with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance